Susceptibility of clinical isolates of Campylobacter jejuni to twenty-five antimicrobial agents
- 1 December 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 18 (6), 681-685
- https://doi.org/10.1093/jac/18.6.681
Abstract
The in-vitro activity of 25 antimicrobial agents against 113 to 161 clinical isolates of Campylobacter jejuni was tested by an agar dilution method. All strains were susceptible to the four aminoglycosides tested, to imipenem, chloramphenicol and norfloxacin. One strain (0.6%) was resistant to each of the following antibiotics: nalidixic acid, erythromycin and clindamycin. The frequency of tetracycline, metronidazole and cotrimoxazole resistance among our isolates was 14.5%, 56.4% and 96% respectively. In general, the β-lactam antibiotics (penicillins and cephalosporins) showed only moderate to poor activity against C. jejuni. Of 159 strains tested, 89.3% produced β-lactamases.Keywords
This publication has 4 references indexed in Scilit:
- Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogensAntimicrobial Agents and Chemotherapy, 1985
- In vitro susceptibility of Campylobacter fetus subsp. jejuni to N-formimidoyl thienamycin, rosaramicin, cefoperazone, and other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1981
- Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolatesAntimicrobial Agents and Chemotherapy, 1981
- Susceptibility of Campylobacter fetus subsp. jejuni to Twenty-Nine Antimicrobial AgentsAntimicrobial Agents and Chemotherapy, 1978